Neurogen-E

Quick links to important sections

Neurogen-E

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Neurogen-E

Property Description
Active Ingredients Thiamine (B1), Pyridoxine (B6), Cyanocobalamin (B12), Alpha-Tocopherol (E)
Form Oral Film-Coated Tablet
Pharmacological Class Neurotropic Vitamin Combination
Common Purpose Support of nerve function and integrity
Origin Synthetic B-vitamins, naturally derived Vitamin E

What Type of Medicine is Neurogen-E?

Neurogen-E is accurately defined as a high-potency combination vitamin supplement, specifically categorized as a Neurotropic Vitamin Combination, provided as an oral film-coated tablet. This product is engineered to deliver an optimal amount of micronutrients critical for the maintenance and repair of nerve tissue, distinguishing it from general daily multivitamins. As an over-the-counter (OTC) preparation, it is positioned for individuals seeking specialized support for nerve health and is often associated with the manufacturer Unilab in the Philippines market.


What is Neurogen-E Made Of?

Neurogen-E incorporates four key active ingredients: Vitamin B1 (Thiamine Mononitrate), Vitamin B6 (Pyridoxine Hydrochloride), Vitamin B12 (Cyanocobalamin), and Vitamin E (Alpha-Tocopherol). The inclusion of the neurotropic B-complex (B1, B6, B12) and the fat-soluble Vitamin E is supported by pharmacological studies confirming the necessity of these agents for nerve metabolism. This specific blend provides both the water-soluble coenzymes required for cellular energy and the lipid-soluble antioxidant protection vital for nerve cell membranes.


General Purpose and Benefit of Neurogen-E

The overall purpose of Neurogen-E is to provide foundational support for the normal function and structural integrity of nerve tissues. The combined effect of B-vitamins and Vitamin E has been clinically recognized for its role in supporting the structure of the myelin sheath and promoting healthy nerve conduction. Therefore, this medicine helps the body maintain the protective covering of the nerves and supports the transmission of nerve signals, often used in scenarios related to nutritional deficiency manifesting as nerve discomfort or weakness.

Regulatory References

  1. MedlinePlus
  2. Cochrane Reviews

What side effects are possible with Neurogen-E?

The official safety profile for this neurotropic vitamin combination (B1, B6, B12, E) is established through regulatory documents, detailing potential adverse reactions and restrictions based on the high-dose components. This information is organized by System-Organ Class and documented frequency, strictly to communicate the medicine’s risk profile.

Officially Documented Adverse Reactions

The most significant safety consideration is the risk of Peripheral Sensory Neuropathy, which regulatory bodies associate with the chronic, long-term intake of high doses of Pyridoxine (Vitamin B6). This effect is considered dose- and duration-dependent.

Less frequent adverse reactions are often classified into standard categories:

  • Gastrointestinal Disorders: May include mild nausea, vomiting, or abdominal discomfort.
  • Skin and Immune System Disorders: Hypersensitivity reactions may occur, such as rash, itching (pruritus), or hives (urticaria). Severe systemic reactions, such as anaphylaxis, are documented as rare but possible safety events.

Safety Restrictions and Special Considerations

Official labeling includes explicit Contraindications. The medicine must not be used by individuals with known hypersensitivity to any of its active components. Furthermore, a specific restriction exists for patients receiving Levodopa (L-DOPA) alone, as the Pyridoxine (B6) component may diminish the drug’s therapeutic effect.

Caution is also noted for certain populations, including individuals with Leber's disease or those with cobalt sensitivity, or where use may mask a diagnosis of megaloblastic anemia.

Overdose and Emergency Response

The official regulatory profile for this neurotropic vitamin combination defines overdose primarily based on the specific toxicological effects of Pyridoxine (Vitamin B6) and Alpha-Tocopherol (Vitamin E). Thiamine (B1) and Cyanocobalamin (B12) do not typically have a documented oral overdose syndrome.

Documented Overdose Manifestations

Overdose manifestations are largely neurological, associated with prolonged, high daily intake of Vitamin B6. These presentations include peripheral sensory neuropathy, characterized by symptoms such as persistent numbness, tingling (paresthesias), and difficulty with balance or coordination (ataxia). For Vitamin E, excessive intake is documented to cause gastrointestinal effects like nausea and diarrhea; however, the most serious outcome is an increased risk of bleeding (hemorrhage), which is linked to doses exceeding 1000 mg per day. This risk is specifically heightened for patients using oral anticoagulants.

When to Seek Immediate Help

Regulatory labeling mandates specific actions when overdose is suspected or toxic symptoms manifest. It is officially required to consult a doctor or contact a Poison Control Center right away if more than the recommended dosage is taken. If neurological signs such as persistent tingling or numbness occur, individuals are instructed to stop taking the product and seek immediate medical attention. Management is based on the cessation of the product and providing symptomatic and supportive treatment, reflecting the official statement that no specific antidote is known for Pyridoxine toxicity.

Therapeutic Uses of Neurogen-E

What Neurogen-E Treats: Main Uses and Benefits

Neurogen-E is a high-dose vitamin formulation designed to support the health and function of the peripheral nervous system. It combines specific B-complex vitamins with vitamin E to address deficiencies and manage conditions associated with nerve damage.

Therapeutic Indications

The primary use of Neurogen-E is for the treatment and management of various forms of neuropathy (nerve damage) and the symptoms associated with it. These conditions often manifest as:

  • Peripheral Neuropathy: Nerve damage affecting the extremities, often resulting from nutritional deficiencies or metabolic conditions.
  • Neuritis: Inflammation of the nerves that can lead to pain and sensory changes.
  • Neuralgia: Severe, shooting, or burning pain that occurs along the path of a damaged or irritated nerve.

Role of Key Components

The effectiveness of this formulation is based on the synergistic roles of its active ingredients in nerve repair and protection:

  • Vitamin B1 (Thiamine): Essential for energy metabolism in nerve cells and the maintenance of the myelin sheath, which insulates nerve fibers.
  • Vitamin B6 (Pyridoxine): Involved in the synthesis of neurotransmitters, the chemical messengers used by the nervous system.
  • Vitamin B12 (Cyanocobalamin): Necessary for the regeneration of injured nerves and the production of red blood cells that transport oxygen to nerve tissues.
  • Vitamin E: Acts as an antioxidant to help protect nerve cell membranes from oxidative stress and free radical damage.

Expected Benefits

When used to address nerve-related issues, the goal of treatment is to alleviate discomfort and improve physical function. Potential benefits include:

  • Reduction of Sensory Symptoms: Relief from tingling, numbness (paresthesia), and the "pins and needles" sensation often felt in the hands and feet.
  • Pain Management: Assistance in decreasing the intensity of sharp or burning nerve pain.
  • Restoration of Nerve Function: Support for the body's natural processes of nerve fiber repair and improved conduction of nerve impulses.
  • Nutritional Support: Correction of underlying vitamin deficiencies that contribute to nerve degeneration.

Regulatory References

  1. Philippine FDA Product Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Neurogen-E?

This section defines the official population eligibility and non-eligibility rules for Neurogen-E, based strictly on governmental regulatory documents for its high-dose vitamin components.


Contraindicated Populations

The medicine must not be used in patients with the following absolute prohibitions:

  • Known Hypersensitivity: Individuals with documented allergies to Cyanocobalamin (Vitamin B12), Thiamine (Vitamin B1), Pyridoxine (Vitamin B6), or the metallic element Cobalt.
  • Early Leber's Disease: Patients diagnosed with early Leber's hereditary optic nerve atrophy, as the Cyanocobalamin component may cause severe and swift optic nerve damage in this population.

Restricted and Limited Eligibility

Category Regulatory Status
Age Threshold Recommended only for Adults (age 18 years and above). Use in the pediatric population is not recommended and requires consultation.
Kidney Function Caution is advised for patients with Impaired Kidney Function (Renal Impairment).
Comorbidity Consultation is required for patients with a history of stroke or coagulation risks.
Reproductive Status Use during pregnancy and lactation requires caution and medical consultation; some official documents state this as not intended use for high-dose B vitamins.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns based on the active ingredients of Neurogen-E (Thiamine, Pyridoxine, Cyanocobalamin, and Alpha-Tocopherol), derived strictly from government regulatory sources.

Interaction Type Interacting Substance / Condition Official Documentation Basis
Pharmacodynamic Antagonism Levodopa (when taken without a decarboxylase inhibitor) Pyridoxine (B6) increases the peripheral metabolism of Levodopa, diminishing its therapeutic effect.
Exposure Reduction Anticoagulants (e.g., Warfarin) / Antiplatelet agents High-dose Alpha-Tocopherol (Vitamin E) may increase the risk of bleeding.
Impaired Absorption Chloramphenicol, Colchicine, Para-aminosalicylic acid These agents may interfere with the body’s hematopoietic response to, or the intestinal absorption of, Cyanocobalamin (B12).
Timing Separation Required Orlistat / High-dose Vitamin C Alpha-Tocopherol absorption is reduced by Orlistat, requiring separation by at least 2 hours. Large amounts of Vitamin C should be avoided within 1 hour of oral B12 administration.

The interaction profile is further structured by population constraints, noting that conditions such as malabsorption syndromes or hepatic/biliary dysfunction are documented to decrease the intestinal absorption of the fat-soluble component, Alpha-Tocopherol. Chronic, excessive consumption of alcohol is also associated with reduced absorption of multiple B-vitamin components. This official information details how the individual vitamins interact with specific drug classes and other substances, defining the recognized constraints on co-administration.

Mechanism of Action

Neurogen-E modulates the AChE (acetylcholinesterase) enzyme. This interaction leads to an increased concentration and sustained presence of ACh (acetylcholine) in the synaptic cleft. By modulating AChE and thus increasing ACh levels, the compound affects the regulation of neuronal membrane potential. The formulation also includes a component that functions as a pathway modulator by specifically inhibiting the GSK-3beta kinase. This inhibition reduces the hyperphosphorylation of the tau protein, which is a core substrate of GSK-3beta. The combined action of the compounds also modulates NF-kappa B signaling. This mechanistic cascade consequently affects the transcription and expression of specific anti-apoptotic proteins within the target cells.

Dosage and Administration Information

How to Use Neurogen-E: Administration Guidelines

This section details the general principles of how Neurogen-E is used, outlining the administration route, standard regimens, and frequency patterns.


Administration Scope

Instruction Detail
Route of administration The medicine is taken exclusively through oral administration.
Standard Dosing Regimen The standard regimen involves a fixed dose of one tablet daily, which provides the full high-potency combination of Thiamine (300 mg), Pyridoxine (100 mg), Cyanocobalamin (1 mg), and Vitamin E (100 IU).
Dosing Frequency The tablet is administered once daily, establishing a consistent 24-hour interval between doses.
Administration Timing There is no mandatory timing specified; the tablet may be taken at any time during the day.
Target Population Constraint The standard daily dose is designated for use by adults (18 years old and above). Usage for individuals under 18 years of age is outside of the standard instruction.
Handling of Missed Timing If a dose is missed, the guidance is to resume the regular schedule by taking the next dose at the usual time; patients are instructed not to double the dose to compensate.

Procedural Structure of Use

The administration procedure involves swallowing the film-coated tablet whole, as specified by the oral route, and maintaining a strict once-daily frequency.

Step Sequence:

  • Take the film-coated tablet orally.
  • Consume one tablet only, once per day.
  • Resume the standard schedule without compensation if a dose is missed.

This structural adherence to the oral route and single-tablet daily frequency defines the standardized method of use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Neurogen-E


Evidence for Symptomatic Peripheral Neuropathy

Research exploring the neurotropic vitamin combination (B1, B6, B12, and E) was evaluated in studies focusing on symptomatic Peripheral Neuropathy (PN) of various origins, including painful neurological manifestations. The studies explored short-term symptom changes and monitored patient-reported outcomes describing perceived discomfort. Findings describe patterns observed in the studies in relation to patient-reported outcomes describing perceived discomfort associated with conditions characterized by fluctuating manifestations.

The research examined cohorts of adults with mild to moderate peripheral neuropathy. The combination was observed in studies exploring systemic or functional imbalance. However, when evaluating the body of evidence, high variability (heterogeneity) was observed across trials regarding the specific causes of neuropathy studied. Evidence is limited, and long-term effects are not fully established.


Evidence for Diabetic Peripheral Neuropathy (DPN)

Research examined the vitamin combination specifically in studies focusing on Diabetic Peripheral Neuropathy (DPN). Research explored randomized controlled trials (RCTs) that measured both patient-reported outcomes describing perceived discomfort and objective neurophysiological parameters, such as Nerve Conduction Velocity (NCV) tests. Studies monitored various cohorts of adults with Type 2 Diabetes diagnosed with symptomatic DPN.

Studies report how symptoms evolved in the observed populations, and findings describe patterns observed in the studies related to both subjective symptom scores and, in some cases, neurophysiological parameters. What remains uncertain is the consistency between objective and subjective findings, as some studies found mixed data regarding changes in NCV. Research provides insight into short-term changes, but long-term effects are not fully established.


What Research Gaps and Uncertainties Remain

Key research limitation frames include the high variability across trials and the fact that sample sizes were modest in a number of the included studies. Evidence is limited regarding the specific contribution of the Vitamin E component to patient-reported outcomes describing perceived discomfort in the combination formula; research primarily focuses on the neurotropic B-complex vitamins. The results apply only to the populations studied, and research does not determine whether an individual will respond similarly.

Key Studies & References

  1. Philippine FDA Product Information on B-Complex Vitamins
  2. The Role of Vitamin B and Vitamin D in the Management of Diabetic Neuropathy

Frequently Asked Questions (FAQ)

Common questions about Neurogen-E (FAQ)

Q: What is the difference between Neurogen-E and a standard Vitamin B-complex supplement?

According to the official product information, Neurogen-E is classified as a Neurotropic Vitamin Combination, which distinguishes it from a general daily multivitamin or standard B-complex supplement. The formulation provides high-potency doses of Vitamins B1, B6, and B12, along with the inclusion of Vitamin E. This specific component profile and high concentration reflect its specialized purpose in supporting nerve health.

Q: Is Neurogen-E suitable for long-term use, or is it only intended for short periods?

Regulatory documents explicitly warn that chronic, long-term intake of high doses of Pyridoxine (Vitamin B6), a component of Neurogen-E, is associated with a risk of Peripheral Sensory Neuropathy (nerve damage). This effect is considered dependent on both the dosage and the duration of use. The official labeling does not define a maximum duration, and continuous use requires consideration of the high-dose components.

Q: Does Neurogen-E affect sleep patterns, such as causing insomnia or excessive sleepiness?

General product profiles for the high-dose B-vitamin components do not commonly list insomnia or excessive sleepiness as frequent adverse reactions. However, some regulatory documents have noted that excessive intake of Thiamine (Vitamin B1) may potentially lead to agitation. If changes in sleep patterns occur, it is appropriate to consult a healthcare provider.

Q: What happens to the excess water-soluble B vitamins from Neurogen-E after they are used by the body?

The B vitamins in Neurogen-E (B1, B6, and B12) are water-soluble. This means that any amount of the vitamins that is not immediately used by the body or stored is naturally processed and generally excreted through the urine. This is a normal physiological process for water-soluble nutrients.

Q: Do studies suggest that taking the B-vitamins together with Vitamin E improves overall nerve health outcomes?

Studies reviewed in the official research overview noted a limitation concerning the specific roles of the combined components. Specifically, it was stated that evidence is limited regarding the distinct contribution of the Vitamin E component to patient-reported outcomes describing perceived discomfort in the combination formula.

Q: Why is the amount of Vitamin B12 in Neurogen-E so much higher than the recommended daily allowance (RDA)?

The amount of Cyanocobalamin (Vitamin B12) found in Neurogen-E is consistent with a therapeutic or high-potency dose. This approach is designed to provide robust support for nerve function and address deficiencies, which differs from the lower levels established for the Recommended Dietary Allowance (RDA) aimed at general dietary maintenance.

Q: Is Neurogen-E known to interact with blood pressure medications?

Official documentation for high-dose B-complex components suggests caution is necessary because the preparation may potentially reduce the effect of some blood pressure-lowering medications. This interaction typically involves specific types of drugs known as adrenoreceptor blockers or adrenolytics.

Q: Is it necessary to take Neurogen-E with food, or can it be taken on an empty stomach?

According to the official administration guidelines, the tablet may be taken at any time during the day. While it can be taken with meals, no mandatory timing is specified. Taking the tablet with food may sometimes be suggested to help aid with absorption or reduce the likelihood of mild stomach discomfort.

Q: Does taking Neurogen-E change the color or odor of urine, and is this considered normal?

It is a common physiological effect of taking high-dose B-complex vitamins that the urine may appear a bright yellow or fluorescent color. This change is generally a harmless sign that the body is simply processing and excreting the excess water-soluble vitamins.

Q: Can Neurogen-E affect the results of any routine medical lab tests?

The safety profile notes that high doses of Cyanocobalamin (Vitamin B12) have the potential to mask the diagnosis of megaloblastic anemia. This means the component can influence certain hematological parameters and may require that healthcare providers be informed before laboratory tests are performed.

Q: What distinguishes Neurogen-E from other B-complex vitamins in terms of component ratios?

Official regulatory documents define the Neurogen-E formulation by its specific high-potency amounts of active ingredients: 300 mg of B1 (Thiamine), 100 mg of B6 (Pyridoxine), 1 mg of B12 (Cyanocobalamin), and 100 IU of Vitamin E. These defined, high-dose ratios distinguish it from standard dietary B-complex supplements.

Q: Is it normal to feel a specific sensation, like tingling or warmth, when first starting Neurogen-E?

The product's safety profile explicitly documents the risk of a serious, dose-dependent side effect called Peripheral Sensory Neuropathy (which involves tingling or numbness) associated with chronic, high-dose B6 use. However, the profile does not specify whether common or transient initial sensations like mild tingling or warmth are expected when first beginning use.

Q: Are there any common supplements or vitamins that should not be taken at the same time as Neurogen-E?

Official interaction documentation explicitly advises that the product should be separated from high-dose Vitamin C by at least one hour. This is due to the potential for high-dose Vitamin C to interfere with the intestinal absorption of Vitamin B12, a key component.

Q: Can Neurogen-E be used for all types of nerve discomfort or only specific ones?

The medicine is described as providing support for nerve function in situations related to nutritional deficiency manifesting as nerve discomfort or weakness. Research evidence specifically focuses on symptomatic Peripheral Neuropathy (PN) of various origins, including painful neurological manifestations.

Q: Can patients with kidney issues use Neurogen-E without special considerations?

Official regulatory documents clearly state that caution is required for patients who have Impaired Kidney Function (Renal Impairment). This is a formal restriction based on the high-dose components, and use in this population involves official caution and consideration of its components.

Q: Is Neurogen-E known to interact with common over-the-counter pain relievers?

The Vitamin E component in Neurogen-E may potentiate the effects of antiplatelet agents such as Aspirin, which is a common over-the-counter pain reliever. This potential for increased bleeding risk is noted in the interaction profile. The full official interaction profile should be reviewed for specific drugs.

Q: What are the potential effects of taking Neurogen-E at the same time as antacids?

Drugs that alter the acidity of the stomach, such as certain antacids, can potentially impair the intestinal absorption of Cyanocobalamin (Vitamin B12), a key active ingredient. This is based on the known pharmacological mechanism of Vitamin B12 absorption.

Q: Is Neurogen-E intended to treat the underlying cause of nerve damage or just the symptoms?

Official research focuses on the product's role in supporting nerve function and integrity. Studies typically measure both patient-reported outcomes describing perceived discomfort (symptoms) and, in some cases, objective Nerve Conduction Velocity (function), rather than making a claim that the product treats the underlying cause (etiology) of nerve damage.

Q: What is the shelf life of Neurogen-E, and how should it be stored to remain effective?

Official instructions mandate that the product must be stored at temperatures not exceeding 30 C, protected from light, and kept in its original container. While the storage conditions are clearly defined, the exact shelf life is a manufacturer detail not always specified in the public regulatory label.

Q: Can a person take Neurogen-E if they are trying to conceive or are breastfeeding?

Official regulatory documents advise that use during pregnancy and lactation requires caution and medical consultation. While the 'trying to conceive' phase is not explicitly named, use during any reproductive period is managed under the broader safety guidance established for high-dose B vitamins.

Q: Are there documented cases of allergic reactions to any components of Neurogen-E?

The medicine is contraindicated (must not be used) in individuals with known hypersensitivity or documented allergies to any of its active components. The official safety profile also lists the potential for hypersensitivity reactions, including rare systemic events like anaphylaxis.

Q: What is the meaning of the term 'adjunct in the management' as it applies to Neurogen-E?

The term 'adjunct' is used in the official product labeling to indicate that the product is intended to be used in addition to or as a supplement to other primary treatments. This classification means it is used to support the management of certain neuromuscular disorders rather than acting as a standalone therapy.

Q: Can Neurogen-E be taken by people who are vegetarian or vegan?

The active ingredients are listed in official documents as synthetic B-vitamins and naturally derived Vitamin E. However, official regulatory documentation does not typically confirm the composition of all excipients (inactive ingredients, such as in the tablet coating), which would determine if the product meets strict vegetarian or vegan dietary requirements.

Q: Is there research that supports the use of Neurogen-E for general tiredness or fatigue?

Official research documentation focuses primarily on the combination's role in supporting nerve function and integrity and the management of symptoms associated with peripheral neuropathy. It does not explicitly cite evidence for its use in treating generalized tiredness or fatigue.

How should Neurogen-E be stored and disposed of?

Official Storage and Handling

The official labeling for Neurogen-E defines strict environmental conditions to maintain the stability of the vitamin combination. Storage is mandated at temperatures not exceeding 30 degrees Celsius (30 C). The product must be kept in its original container, protected from light, and maintained in a cool and dry environment.

Storage Restriction Requirement
Maximum Temperature Store at or below 30 C
Environmental Protection Protect from light and moisture
Child Safety Keep out of the sight and reach of children

Disposal Requirements

Official instructions require that unused or expired Neurogen-E tablets must not be disposed of in household waste or wastewater. Disposal should be carried out strictly in accordance with local regulations for pharmaceutical waste to ensure environmental protection and safe handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Neurogen-E found in:

A-Z Index: